Titlebook: Nuclear Cardiology and Cardiac Magnetic Resonance; Physiology, Techniqu Ernst Evert Wall Book 1992 E.E. van der Wall 1992 SPECT.angiography

Emg827

arabesque

Clinical significance of silent ischemia and implications for treatment: Role of radionuclide technied can only be inferred from indirect evidence suggested by preliminary trials. Only randomized controlled clinical trials will yield the definite answers as to the effects of treatment on clinical outcome.

坦白

What’s new in cardiac imagingn, in particular after reperfusion therapy. A variety of new imaging approaches has been proposed, both with gamma- and positron-emitting tracers. This chapter will address the most important new cardiac imaging agents and the latest developments with the currently used tracers.

Expiration

avulsion

om the fields of nuclear medicine and cardiology and the cooperation of both specialties has been very productive. At present, nuclear cardiology techniques belong to the routine armamentarium of the clinical cardiologist. Results obtained by perfusion markers, metabolic tracers, and radionuclide an

Calibrate

Alternative stress methods in the evaluation of coronary artery diseasebutamine) in combination with radionuclide techniques has gained much interest. This chapter will consider the usefulness and role of alternative stress testing to provoke myocardial ischemia, with emphasis on pharmacologic stress testing in conjunction with thallium-201 myocardial perfusion scintigraphy.

modifier

Book 1992lds of nuclear medicine and cardiology and the cooperation of both specialties has been very productive. At present, nuclear cardiology techniques belong to the routine armamentarium of the clinical cardiologist. Results obtained by perfusion markers, metabolic tracers, and radionuclide angiography

追蹤

xt presents major developments of the last couple of decades, together with a unified, meta-analytic framework within which surrogates can be evaluated from several angles. Methodological development is coupled978-1-4419-1906-9978-0-387-27080-7Series ISSN 1431-8776 Series E-ISSN 2197-5671

惡意

bioavailability